Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1988 1
1990 3
1991 2
1993 1
1995 3
1998 3
1999 1
2000 1
2001 4
2002 2
2003 3
2004 3
2005 2
2006 3
2007 1
2008 2
2009 4
2010 3
2011 7
2012 6
2013 5
2014 8
2015 6
2016 14
2017 18
2018 15
2019 9
2020 18
2021 11
2022 8
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30418155

149 results

Results by year

Filters applied: . Clear all
Page 1
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.
Leuthard DS, Duda A, Freiberger SN, Weiss S, Dommann I, Fenini G, Contassot E, Kramer MF, Skinner MA, Kündig TM, Heath MD, Johansen P. Leuthard DS, et al. J Immunol. 2018 May 1;200(9):3151-3159. doi: 10.4049/jimmunol.1800035. Epub 2018 Mar 28. J Immunol. 2018. PMID: 29592962 Free PMC article.
Clinical use of adjuvants in allergen-immunotherapy.
Klimek L, Schmidt-Weber CB, Kramer MF, Skinner MA, Heath MD. Klimek L, et al. Expert Rev Clin Immunol. 2017 Jun;13(6):599-610. doi: 10.1080/1744666X.2017.1292133. Epub 2017 Feb 23. Expert Rev Clin Immunol. 2017. PMID: 28162007 Review.
Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.
Florido-López JF, Andreu-Balaguer C, Escudero C, Seoane-Rodríguez M, Hernández M, Navarro-Seisdedos LÁ, Torrecillas-Toro M, Anton-Girones M, Herrero-Lifona L, Brugaletta D, Macías J, Pineda R, Lara MÁ, López-Caballero J, Rojas MJ. Florido-López JF, et al. World Allergy Organ J. 2020 Dec 18;13(12):100487. doi: 10.1016/j.waojou.2020.100487. eCollection 2020 Dec. World Allergy Organ J. 2020. PMID: 33376572 Free PMC article.
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI).
Jensen-Jarolim E, Bachmann MF, Bonini S, Jacobsen L, Jutel M, Klimek L, Mahler V, Mösges R, Moingeon P, O Hehir RE, Palomares O, Pfaar O, Renz H, Rhyner C, Roth-Walter F, Rudenko M, Savolainen J, Schmidt-Weber CB, Traidl-Hoffmann C, Kündig T. Jensen-Jarolim E, et al. Allergy. 2020 Apr;75(4):746-760. doi: 10.1111/all.14134. Allergy. 2020. PMID: 31774179 Free article.
Adjuvants and vector systems for allergy vaccines.
Moingeon P, Lombardi V, Saint-Lu N, Tourdot S, Bodo V, Mascarell L. Moingeon P, et al. Immunol Allergy Clin North Am. 2011 May;31(2):407-19, xii. doi: 10.1016/j.iac.2011.03.001. Immunol Allergy Clin North Am. 2011. PMID: 21530828 Review.
149 results